Why We Invested in Resilient Lifescience — Preventing Opiod Overdose



Energized to announce our financial commitment in Resilient Lifescience, which is using on the opioid epidemic by acquiring a wearable method to detect and automatically reverse overdoses. Tau Ventures is an AI-first fund in Silicon Valley investing mostly in seed and we at times take earlier or afterwards bets when we see enormous promise. We are also investing in US / Canada but in remarkable scenarios will take into consideration a offer outside. Resilient was founded in 2022 in Pittsburgh and amazed us with (1) a solid require, (2) constructing an execution-focused workforce, and (3) their organization strategy.

1) The Have to have

The opioid disaster is truly a tragedy that expenses $1T for every yr, touching all the 5Ps (payors, companies, sufferers, pharma, policymakers). Especially, tin this article are now around 75,000 opioid overdose fatalities for each yr in the US, and the bulk of them happen when no one is about to administer support (CDC, rand.org). We are particularly familiar with this room offered our investment decision in Marigold Health.


2) The Team

We believed the cofounder’s backgrounds converse for on their own: https://www.linkedin.com/in/bradfordholden and https://www.linkedin.com/in/charlierproctor. CEO Brad was a Marine for 4 many years like currently being a Platoon Commander in Afghanistan. CTO Charlie was an engineer at Google. They met at Infinitus, an additional Tau portfolio firm, and their CEO invested personally and is the a single who introed us.


3) Company Tactic

Components is hard, as the bar for obtaining almost everything right is considerably greater than in program, even far more so in health care. Producing and distribution prices also build a really distinct value composition than application ventures. We see a pathway for them to acquire additional knowledge and reinforce the analytics / AI piece of the product. We appreciate the CEO’s system to do shopper discovery and subvert the basic archetype of clinical gadgets becoming capital intensive. We also subscribe to their thesis that remaining in Pittsburgh will preserve expenditures very low and allow for them accessibility to terrific expertise, primarily in engineering from Carnegie Mellon.

blankWe are honored and energized to be element of Resilient’s journey, employing know-how to fix a large problem. Extra at https://www.resilient.bio.

Initially printed on “Information Driven Investor,” am content to syndicate on other platforms. I am the Handling Companion and Cofounder of Tau Ventures with 20 a long time in Silicon Valley throughout corporates, individual startup, and VC cash. These are purposely shorter articles concentrated on practical insights (I simply call it gldr — fantastic duration did examine). Lots of of my writings are at https://www.linkedin.com/in/amgarg/element/recent-activity/posts and I would be stoked if they get people today intrigued adequate in a subject matter to explore in even more depth. If this short article experienced useful insights for you comment absent and/or give a like on the posting and on the Tau Ventures’ LinkedIn web site, with owing thanks for supporting our work. All viewpoints expressed listed here are my possess.